Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Diagnostic Power of Blood Parameters as Screening Markers in Gastric Cancer Patients

  • Pietrzyk, Lukasz (Department of Didactics and Medical Simulation, Chair of Human Anatomy, Medical University of Lublin) ;
  • Plewa, Zbigniew (Department of General, Oncological and Minimally Invasive Surgery, 1st Military Clinical Hospital) ;
  • Denisow-Pietrzyk, Marta (Department of Didactics and Medical Simulation, Chair of Human Anatomy, Medical University of Lublin) ;
  • Zebrowski, Remigiusz (Department of General, Oncological and Minimally Invasive Surgery, 1st Military Clinical Hospital) ;
  • Torres, Kamil (Department of Didactics and Medical Simulation, Chair of Human Anatomy, Medical University of Lublin)
  • Published : 2016.09.01
⟨ Previous Next ⟩

Abstract

Background: Gastric cancer (GC) is the fifth most common cancer worldwide. Since development is usually asymptomatic, it is generally diagnosed at an advanced stage. The value of screening in patients with nonspecific symptoms for GC is controversial. Aim: The study aimed to evaluate whether hematological parameters (platelet count (PC), mean platelet volume (MPV), MPV/PC ratio, red blood cell distribution width (RDW), neutrophil to lymphocyte ratio (NLR), and platelet to lymphocyte ratio (PLR)) are useful markers to differentiate between gastric cancer patients and healthy individuals. Materials and Methods: Sixty-one patients with gastric cancer and sixty-one healthy individuals were enrolled to the survey and retrospective analysis of selected blood parameters were performed. Results: The mean values of PC, MPV, RDW, NLR, and PLR were significantly higher in GC patients compared to the control group. No statistical differences were observed in MPV/PC ratios. Likewise, no significant statistical differences were revealed in values of blood parameters among TNM stage groups. The RDW showed the highest diagnostic specificity and sensitivity. Conclusions: Hematological parameters: PC, MPV, RDW, NLR, PLR have diagnostic power and can discriminate patients with gastric cancer from patients without cancer. Blood parameters compared with clinical symptoms might alert physicians and patients and lead to performancce of upper gastrointestinal endoscopy, the gold standard in gastric cancer screening and therebly increase the early detection of cancer.

Keywords

References

  1. Aksoy S, Kilickap S, Hayran M, et al (2008). Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors. Int J Lab Hematol, 30, 214-19. https://doi.org/10.1111/j.1751-553X.2007.00947.x
  2. Albayrak S, Zengin K, Tanik S, et al (2014). Red cell distribution width as a predictor of prostate cancer progression. Asian Pac J Cancer Prev, 15, 7781-4. https://doi.org/10.7314/APJCP.2014.15.18.7781
  3. Aldemir MN, Turkeli M, Simsek M, et al (2015). Prognostic value of baseline neutrophil-lymphocyte and plateletlymphocyte ratios in local and advanced gastric cancer patients. Asian Pac J Cancer Prev, 16, 5933-7. https://doi.org/10.7314/APJCP.2015.16.14.5933
  4. Ay S, Eryilmaz MA, Aksoy N, et al (2015). Is early detection of colon cancer possible with red blood cell distribution width? Asian Pac J Cancer Prev, 16, 753-6. https://doi.org/10.7314/APJCP.2015.16.2.753
  5. Azab B, Torbey E, Singh J, et al (2011). Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction. Platelets, 22, 557-66. https://doi.org/10.3109/09537104.2011.584086
  6. Balta S, Demirkol S, Unlu M, Celik T (2014). Other inflammatory markers should be kept in mind when assessing the mean platelet volume. Platelets, 25, 552-3. https://doi.org/10.3109/09537104.2013.775643
  7. Borne Y, Smith JG, Melander O, Engstrom G (2014). Red cell distribution width in relation to incidence of coronary events and case fatality rates: a population-based cohort study. Heart, 100, 1119-24. https://doi.org/10.1136/heartjnl-2013-305028
  8. Bornschein J, Kandulski A, Selgrad M, Malfertheiner P (2010). From gastric inflammation to gastric cancer. Dig Dis, 28, 609-14. https://doi.org/10.1159/000320061
  9. Cakal B, Akoz AG, Ustundag Y, et al (2009). Red cell distribution width for assessment of activity of inflammatory bowel disease. Dig Dis Sci, 54, 842-7. https://doi.org/10.1007/s10620-008-0436-2
  10. Cancer Research UK [Internet]. Available: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/stomach-cancer. Accessed 2015 Feb 1.
  11. Cho SY, Yang JJ, Suh JT, et al (2013). Mean platelet volume/platelet count ratio in anemia. Platelets, 24, 244-5. https://doi.org/10.3109/09537104.2012.684734
  12. Cho SY, Yang JJ, You E, et al (2013). Mean platelet volume/platelet count ratio in hepatocellular carcinoma. Platelets, 24, 375-7 https://doi.org/10.3109/09537104.2012.701028
  13. Demirkol S, Balta S, Kucuk U, Celik T (2015). Mean platelet volume may indicate early diagnosed gastric cancer based on inflammation. Platelets, 26, 99-100. https://doi.org/10.3109/09537104.2013.799646
  14. Ernst P (1999). Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther, 13, 13-18. https://doi.org/10.1046/j.1365-2036.1999.00003.x
  15. Ferlay J, Soerjomataram I, Ervik M, et al (2013). Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr. Accessed 2015 Feb 1.
  16. Fichtner-Feigl S, Kesselring R, Strober W (2015). Chronic inflammation and the development of malignancy in the GI tract. Trends Immunol, 36, 451-9. https://doi.org/10.1016/j.it.2015.06.007
  17. Fock KM (2014). Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther, 40, 250-60. https://doi.org/10.1111/apt.12814
  18. Fock KM, Talley N, Moayyedi P, et al (2008). Asia-pacific gastric cancer consensus conference. asia-pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol, 23, 351-65. https://doi.org/10.1111/j.1440-1746.2008.05314.x
  19. Gungor T, Kanat-Pektas M, Sucak A, Mollamahmutoglu L (2009). The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet, 279, 53-6. https://doi.org/10.1007/s00404-008-0673-9
  20. Han JS, Park TS, Cho SY, Joh JH, Ahn HJ (2013). Increased mean platelet volume and mean platelet volume/platelet count ratio in Korean patients with deep vein thrombosis. Platelets, 24, 590-3. https://doi.org/10.3109/09537104.2012.748187
  21. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ (2009). Gastric cancer. Lancet, 374, 477-90. https://doi.org/10.1016/S0140-6736(09)60617-6
  22. He W, Yin C, Guo G, et al (2013). Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol, 30, 439. https://doi.org/10.1007/s12032-012-0439-x
  23. Hsu JT, Liao CK, Le PH, et al (2015). Prognostic value of the preoperative neutrophil to lymphocyte ratio in resectable gastric cancer. Medicine (Baltimore), 94, 1589. https://doi.org/10.1097/MD.0000000000001589
  24. Ikeda M, Furukawa H, Imamura H, et al (2002). Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol, 9, 287-91. https://doi.org/10.1007/BF02573067
  25. Inagaki N, Kibata K, Tamaki T, Shimizu T, Nomura S (2014). Prognostic impact of the mean platelet volume/platelet count ratio in terms of survival in advanced non-small cell lung cancer. Lung Cancer, 83, 97-101. https://doi.org/10.1016/j.lungcan.2013.08.020
  26. Jiang Y, Xu H, Jiang H, Ding S, Zheng T (2016). Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence. Cancer Biomark.
  27. Kandemir EG, Mayadagli A, Karagoz B, et al (2005). Prognostic significance of thrombocytosis in node-negative colon cancer. J Int Med Res, 33, 228-35. https://doi.org/10.1177/147323000503300211
  28. Kilincalp S, Ekiz F, Basar O, et al (2014). Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets, 25, 592-4. https://doi.org/10.3109/09537104.2013.783689
  29. Kim DK, Oh SY, Kwon HC, et al (2009). Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer, 9, 155. https://doi.org/10.1186/1471-2407-9-155
  30. Kisucka J, Butterfield CE, Duda DG, et al (2003). Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A, 103, 855-60.
  31. Kose M, Celik F, Kose SK, Arioz DT, Yilmazer M (2015). Could the platelet-to-lymphocyte ratio be a novel marker for predicting invasiveness of cervical pathologies? Asian Pac J Cancer Prev, 16, 923-6. https://doi.org/10.7314/APJCP.2015.16.3.923
  32. Lee S, Oh SY, Kim SH, et al (2013). Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer, 13, 350. https://doi.org/10.1186/1471-2407-13-350
  33. Leung WK, Wu MS, Kakugawa Y, et al (2008) Asia pacific working group on gastric cancer. screening for gastric cancer in asia: current evidence and practice. Lancet Oncol, 9, 279-87. https://doi.org/10.1016/S1470-2045(08)70072-X
  34. Li QQ, Lu ZH, Yang L, et al (2014). Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev, 15, 945-50. https://doi.org/10.7314/APJCP.2014.15.2.945
  35. Lian L, Xia XY, Zhou C, et al (2015). Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Cancer Biomark, 15, 899-907. https://doi.org/10.3233/CBM-150534
  36. Lippi G, Targher G, Montagnana M, et al (2009). Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med, 133, 628-32.
  37. Lupia E, Goffi A, Bosco O, Montrucchio G (2012). Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases. Mediators Inflamm, 2012, 390892.
  38. Manz DH, Blanchette NL, Paul BT, Torti FM, Torti SV (2016). Iron and cancer: recent insights. Ann NY Acad Sci, 1-12.
  39. Montagnana M, Cervellin G, Meschi T, Lippi G (2012). The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med, 50, 635-41.
  40. Nash GF, Turner LF, Scully MF, Kakkar AK (2002). Platelets and cancer. Lancet Oncol, 3, 425-30. https://doi.org/10.1016/S1470-2045(02)00789-1
  41. Osada J, Rusak M, Kamocki Z, Dabrowska MI, Kedra B (2010). Platelet activation in patients with advanced gastric cancer. Neoplasma, 57, 145-150. https://doi.org/10.4149/neo_2010_02_145
  42. Pietrzyk L, Torres A, Maciejewski R, Torres K (2015). Obesity and obese-related chronic low-grade inflammation in promotion of colorectal cancer development. Asian Pac J Cancer Prev, 16, 4161-8. https://doi.org/10.7314/APJCP.2015.16.10.4161
  43. Qun-Xiong P, Zi-Jian S, Jian-Hua Z, Chong-Ren W, Shao-Ying K (2015). A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. Onco Targets Ther, 8, 1375-85.
  44. Sategna Guidetti C, Scaglione N, Martini S (2002). Red cell distribution width as a marker of coeliac disease: a prospective study. Eur J Gastroenterol Hepatol, 14, 177-81. https://doi.org/10.1097/00042737-200202000-00012
  45. Seretis C, Seretis F, Lagoudianakis E, Gemenetzis G, Salemis NS (2013). Is red cell distribution width a novel biomarker of breast cancer activity? Data from a pilot study. Clin Med Res, 5, 121-6.
  46. Shimada H, Takiguchi N, Kainuma O, et al (2010). High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer, 13, 170-6. https://doi.org/10.1007/s10120-010-0554-3
  47. Slavka G, Perkmann T, Haslacher H, et al (2011). Mean platelet volume may represent a predictive parameter for over all vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol, 31, 1215-8. https://doi.org/10.1161/ATVBAHA.110.221788
  48. Sobin LH, Gospodarowicz MK, Wittekind C (2010). TNM Classification of Malignant Tumours. 7th ed. Hoboken, NJ: Wiley-Blackwell.
  49. Subhash VV, Ho B (2015). Inflammation and proliferationa causal event of host response to Helicobacter pylori infection. Microbiol, 161, 1150-60. https://doi.org/10.1099/mic.0.000066
  50. Templeton AJ, Ace O, McNamara MG, et al (2014). Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev, 23, 1204-12. https://doi.org/10.1158/1055-9965.EPI-14-0146
  51. Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR (1984). Platelet size and age determine platelet function independently. Blood, 63, 1372-5.
  52. Tuzun A, Keskin O, Yakut M, Kalkan C, Soykan I (2014). The predictive value of mean platelet volume, plateletcrit and red cell distribution width in the differentiation of autoimmune gastritis patients with and without type I gastric carcinoid tumors. Platelets, 25, 363-6. https://doi.org/10.3109/09537104.2013.821607
  53. Vakkila J, Lotze MT (2004). Inflammation and necrosis promote tumour growth. Nat Rev Immunol, 4, 641-8. https://doi.org/10.1038/nri1415
  54. Voutsadakis IA (2014). Thrombocytosis as a prognostic marker in gastrointestinal cancers. World J Gastrointest Oncol, 6, 34-40. https://doi.org/10.4251/wjgo.v6.i2.34
  55. Wang FM, Xu G, Zhang Y, Ma LL (2014). Red cell distribution width is associated with presence, stage, and grade in patients with renal cell carcinoma. Dis Markers, 2014, 860419.
  56. Yamanaka T, Matsumoto S, Teramukai S, et al (2007). The base line ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncol, 73, 215-20. https://doi.org/10.1159/000127412
  57. Yu L, Lv CY, Yuan AH, Chen W, Wu AW (2015). Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer. World J Gastroenterol, 21, 6280-6. https://doi.org/10.3748/wjg.v21.i20.6280